BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 10756004)

  • 21. HTLV-1 gene expression by defective proviruses in an infected T-cell line.
    Bhat NK; Adachi Y; Samuel KP; Derse D
    Virology; 1993 Sep; 196(1):15-24. PubMed ID: 8356792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human T cell lymphotropic virus type I (HTLV-I) p12I is dispensable for HTLV-I transmission and maintenance of infection in vivo.
    Furukawa Y; Usuku K; Izumo S; Osame M
    AIDS Res Hum Retroviruses; 2004 Oct; 20(10):1092-9. PubMed ID: 15585100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human T-cell leukemia virus type 1 (HTLV-1) infection of mice: proliferation of cell clones with integrated HTLV-1 provirus in lymphoid organs.
    Tanaka M; Sun B; Fang J; Nitta T; Yoshida T; Kohtoh S; Kikukawa H; Hanai S; Uchida K; Miwa M
    J Virol; 2001 May; 75(9):4420-3. PubMed ID: 11287593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
    Ramirez E; Cartier L; Torres M; Barria M
    J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of alternatively spliced pX mRNAs in HTLV-I-infected cell lines.
    Cereseto A; Berneman Z; Koralnik I; Vaughn J; Franchini G; Klotman ME
    Leukemia; 1997 Jun; 11(6):866-70. PubMed ID: 9177442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective human T-lymphotropic virus type 1 provirus in asymptomatic carriers.
    Takenouchi H; Umeki K; Sasaki D; Yamamoto I; Nomura H; Takajo I; Ueno S; Umekita K; Kamihira S; Morishita K; Okayama A
    Int J Cancer; 2011 Mar; 128(6):1335-43. PubMed ID: 20473938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long Terminal Repeat 5' Region from Patients with Tropical Spastic Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy and Asymptomatic Carriers.
    Rego FF; de Oliveira T; Giovanetti M; Galvão-Castro B; Gonçalves Mde S; Alcantara LC
    AIDS Res Hum Retroviruses; 2016 Mar; 32(3):279-83. PubMed ID: 26472535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Rajaei T; Farajifard H; Rafatpanah H; Bustani R; Valizadeh N; Rajaei B; Rezaee SA
    Med Microbiol Immunol; 2017 Jun; 206(3):195-201. PubMed ID: 28378248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternatively spliced mRNA of the pX region of human T lymphotropic virus type I proviral genome.
    Furukawa K; Furukawa K; Shiku H
    FEBS Lett; 1991 Dec; 295(1-3):141-5. PubMed ID: 1765145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia.
    Tamiya S; Matsuoka M; Etoh K; Watanabe T; Kamihira S; Yamaguchi K; Takatsuki K
    Blood; 1996 Oct; 88(8):3065-73. PubMed ID: 8874205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy.
    Kubota R; Fujiyoshi T; Izumo S; Yashiki S; Maruyama I; Osame M; Sonoda S
    J Neuroimmunol; 1993 Feb; 42(2):147-54. PubMed ID: 8429100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of HTLV-I-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particles.
    Nicot C; Astier-Gin T; Edouard E; Legrand E; Moynet D; Vital A; Londos-Gagliardi D; Moreau JP; Guillemain B
    Virus Res; 1993 Dec; 30(3):317-34. PubMed ID: 8109163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness.
    Adaui V; Verdonck K; Best I; González E; Tipismana M; Arévalo J; Vanham G; Campos M; Zimic M; Gotuzzo E
    J Neurovirol; 2006 Dec; 12(6):456-65. PubMed ID: 17162661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial transmission and minimal sequence variability of human T-lymphotropic virus type I (HTLV-I) in Zaire.
    Liu HF; Vandamme AM; Kazadi K; Carton H; Desmyter J; Goubau P
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1135-42. PubMed ID: 7826698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
    Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
    Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transmission of human T-cell leukemia virus type 1 to mice.
    Fang J; Kushida S; Feng R; Tanaka M; Kawamura T; Abe H; Maeda N; Onobori M; Hori M; Uchida K; Miwa M
    J Virol; 1998 May; 72(5):3952-7. PubMed ID: 9557681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Defective proviruses of the human T-cell leukemia virus: structure and classification].
    Bavykin AS; Morozov VA
    Vopr Virusol; 2001; 46(5):4-9. PubMed ID: 11715708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. cDNA sequencing confirms HTLV-I expression in adult T-cell leukemia/lymphoma and different sequence variations in vivo and in vitro.
    Berneman ZN; Gartenhaus RB; Reitz MS; Klotman ME; Gallo RC
    Leukemia; 1992; 6 Suppl 3():67S-71S. PubMed ID: 1602830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective provirus form of human T-cell leukemia virus type I in adult T-cell leukemia/lymphoma: clinicopathological features.
    Ohshima K; Kikuchi M; Masuda Y; Kobari S; Sumiyoshi Y; Eguchi F; Mohtai H; Yoshida T; Takeshita M; Kimura N
    Cancer Res; 1991 Sep; 51(17):4639-42. PubMed ID: 1873809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencers of HTLV-1 and HTLV-2: the pX-encoded latency-maintenance factors.
    Harrod R
    Retrovirology; 2019 Sep; 16(1):25. PubMed ID: 31492165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.